CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...